Octave Specialty (OSG) Cost of Revenue (2021 - 2026)

Octave Specialty's Cost of Revenue history runs 6 years deep, the most recent figure standing at $19.7 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 87.49% year-over-year to $19.7 million in Q1 2026; TTM through Mar 2026 was $56.4 million, a 11.59% decrease from a year earlier, with the FY2025 full-year figure at $47.2 million, down 35.02% from the prior year.
• Cost of Revenue improved to $19.7 million in Q1 2026 per OSG's latest filing, from $11.3 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $353.0 million in Q3 2022 and bottomed at -$331.9 million in Q4 2022.
• The 5-year median for Cost of Revenue is $12.0 million (2022), against an average of $13.7 million.
• Biggest YoY gain for Cost of Revenue was 541.82% in 2022; the steepest drop was 354.7% in 2022.
• Year by year, Cost of Revenue stood at -$331.9 million in 2022, then surged by 105.06% to $16.8 million in 2023, then slumped by 41.53% to $9.8 million in 2024, then increased by 15.34% to $11.3 million in 2025, then surged by 73.64% to $19.7 million in 2026.
• Per Business Quant, the three latest OSG Cost of Revenue figures stand at $19.7 million (Q1 2026), $11.3 million (Q4 2025), and $14.4 million (Q3 2025).